Medical devices, healthcare technology and the business of care
510(k) clearance · K262091

FRAXION Spinal Fixation System

Ortler Global Tibbi Gerecler Anonim Sirketi · Decision date Sep 17, 2026

MEDTECHLEDGER EXPLANATIONK262091

What did the FDA decide?

The FDA's 510(k) record K262091 covers the FRAXION Spinal Fixation System, submitted by Ortler Global Tibbi Gerecler Anonim Sirketi of Ankara, Turkey. The device falls under the Thoracolumbosacral Pedicle Screw System classification, regulation number 888.3070, with primary product code NKB and subsequent codes KWP and KWQ; the regulation medical specialty and review panel are both listed as Orthopedic. The application was received on 06/22/2026 as a Traditional 510(k), was not reviewed by a third party, and was not a combination product.

On 09/17/2026 the FDA recorded a decision of Substantially Equivalent (SESE), which for a 510(k) means clearance to market rather than premarket approval. The record does not include a summary statement, so the specific predicates cited, the components or changes assessed, and any performance data supporting equivalence are not available here. No predetermined change control plan was authorized.

Because the underlying review documentation is absent from this source, the basis for the equivalence finding and any device-specific limitations remain unknown and should be confirmed against the full FDA record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 17, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262091
Regulatory pathway
510(k) premarket notification
Product code
NKB
Decision code
SESE
Decision date
Sep 17, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Thoracolumbosacral Pedicle Screw System.

Product code
NKB
FDA device class
2

FDA decision timeline

  1. K262091 received

    Application receipt date recorded by FDA.

  2. K262091 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NKB

Product / regulatory recordCompanyPathwayDecision dateSource
SeaSpine Orthopedics Corporation510(k) clearanceOct 29, 2026FDA
GS Medical Co., Ltd.510(k) clearanceOct 2, 2026FDA
Tdm Co., Ltd.510(k) clearanceOct 1, 2026FDA
Duet Spine Holdings, LLC510(k) clearanceSep 30, 2026FDA
Spinal Alignment Solutions, Inc.510(k) clearanceSep 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Ortler Global Tibbi Gerecler Anonim Sirketi

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Ankara

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records